Development of a vaccine against Newcastle Disease and antimicrobials for Salmonella serovars -

dc.contributor.authorMurtada, Mohammad Rashid
dc.contributor.departmentFaculty of Agricultural and Food Sciences
dc.contributor.departmentDepartment of Agriculture
dc.contributor.institutionAmerican University of Beirut
dc.date2017
dc.date.accessioned2017-12-12T08:03:59Z
dc.date.available2017-12-12T08:03:59Z
dc.date.copyright2018-02
dc.date.issued2017
dc.date.submitted2017
dc.descriptionThesis. M.S. American University of Beirut. Department of Agriculture, 2017. ST:6572
dc.descriptionAdvisor : Dr. Elie Barbour, Professor, Agriculture ; Members of Committee : Dr. Imad Toufeili, Professor, Nutrition and Food Sciences ; Dr. Youssef Abou Jawdeh, Professor, Agriculture ; Dr. Mike Osta, Associate Professor, Biology.
dc.descriptionIncludes bibliographical references (leaves 94-109)
dc.description.abstractThe thesis is divided into two parts namely, studies A and B. The objective of study A was to conduct a phylogenetic analysis on the predominant v-NDV strain in Lebanon, to develop an autogenous Newcastle Disease Virus (NDV) vaccine aiming at the control of v-NDV, and to evaluate its degree of protection and immunity in Eimeria-infected birds. A blend of eucalyptus and peppermint essential oils was also incorporated in this study to explore if essential oils have any immunopotentiating effect when administered to birds subjected to v-NDV and Eimeria challenges. A controlled challenge trial was conducted. Eighty day-old chicks were divided evenly into 8 different experimental treatments. Treatments 1, 2 and 3 were vaccinated with the developed NDV vaccine at d1 and d14, and received Eimeria challenge at d21 and v-NDV challenge at d28. The positive control Treatments 4 and 5 did not receive any NDV vaccination, and received both challenges. Treatments 6, 7, and 8 received the developed NDV vaccine, however they did not receive any challenge, acting as negative control for NDV. Evaluation of protection included an assessment of performance parameters namely, the percent weight gain, feed conversion, mortality, and specific acquired immunity to the hemagglutinin and fusion proteins of the v-NDV. The priming and boosting with the developed autogenous vaccine conferred a 100 percent survival in Eimeria-infected and uninfected birds that were challenged with v-NDV compared to 0.0percent and 30.0percent survivals in unvaccinated-challenged controls (P0.05). The acquired HI titers to hemagglutinin and fusion proteins of genotype VIc Lebanese v-NDV isolate were significantly higher in the vaccinated birds compared to unvaccinated-challenged controls at 34 days of age (P0.05). This study uncovered the high protection by killed autogenous ND vaccine against a controlled bivalent challenge with homologous v-NDV of genotype VIc and Eimeria spp. Study B aimed at the identification of the Salmonella serovars involved in outbreaks that led to hospita
dc.format.extent1 online resource (xi, 109 leaves) : illustrations (some color)
dc.identifier.otherb19155359
dc.identifier.urihttp://hdl.handle.net/10938/21048
dc.language.isoen
dc.relation.ispartofTheses, Dissertations, and Projects
dc.subject.classificationST:006572
dc.subject.lcshPoultry -- Virus diseases -- Lebanon.
dc.subject.lcshNewcastle disease -- Lebanon.
dc.subject.lcshVaccines -- Lebanon.
dc.subject.lcshAnti-infective agents.
dc.subject.lcshSalmonella -- Lebanon.
dc.subject.lcshEssences and essential oils -- Lebanon.
dc.titleDevelopment of a vaccine against Newcastle Disease and antimicrobials for Salmonella serovars -
dc.typeThesis

Files